Last 12 months
Inside the activity.
0 purchase rows · 37 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 12 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 26, 2019 Filed Nov 27, 2019 19:58 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
Exercise / conversionCommon Stock | 4,000 | $1.16 | $4,640.00 |
DisclosureSEC source: 0001209191-19-058295 · doc4.xml · nonDerivative · entry 1 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379,824 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 1,032 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on September 9, 2019. Read SEC document |
| August 15, 2019 Filed Apr 8, 2020 17:46 UTC |
KHOSLA CHAITAN PHDDirector
|
GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $9.99 | $0.00 |
DisclosureSEC source: 0001209191-20-023949 · doc4.xml · derivative · entry 1 KHOSLA CHAITAN PHD · CIK 0001135139 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2029-08-14 Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 22:15 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
SaleCommon Stock | 10,792 | $8.85 | $95,535.10 |
DisclosureSEC source: 0001209191-19-045195 · doc4.xml · nonDerivative · entry 1 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 374,792 F1 · kind: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.80 to $9.2504, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Includes 1,753 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 8, 2019. Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 22:17 UTC |
Liu David YChief Scientific Officer
|
SaleCommon Stock | 3,395 | $8.85 | $30,044.05 |
DisclosureSEC source: 0001209191-19-045196 · doc4.xml · nonDerivative · entry 1 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,802 F1 · kind: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.80 to $9.2255, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. F3 · balance_after: Includes 2,000 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 8, 2019. Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 18:26 UTC |
KHOSLA CHAITAN PHDDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $11.80 | $0.00 |
DisclosureSEC source: 0001209191-19-036203 · doc4.xml · derivative · entry 1 KHOSLA CHAITAN PHD · CIK 0001135139 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2029-06-06 F1 · derivative.exercise_date: The shares subject to this option shall vest at the earlier of (i) June 7, 2020, or (ii) the date of the 2020 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan). Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 18:28 UTC |
Noonberg Sarah B.Director
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $11.80 | $0.00 |
DisclosureSEC source: 0001209191-19-036204 · doc4.xml · derivative · entry 1 Noonberg Sarah B. · CIK 0001706301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2029-06-06 F1 · derivative.exercise_date: The shares subject to this option shall vest at the earlier of (i) June 7, 2020, or (ii) the date of the 2020 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan). Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 22:33 UTC |
Waddill William D.Director
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $11.80 | $0.00 |
DisclosureSEC source: 0001209191-19-036214 · doc4.xml · derivative · entry 1 Waddill William D. · CIK 0001553338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2029-06-06 F1 · derivative.exercise_date: The shares subject to this option shall vest at the earlier of (i) June 7, 2020, or (ii) the date of the 2020 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan). Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 22:31 UTC |
Williams Lewis TDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $11.80 | $0.00 |
DisclosureSEC source: 0001209191-19-036211 · doc4.xml · derivative · entry 1 Williams Lewis T · CIK 0001475714 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2029-06-06 F1 · derivative.exercise_date: The shares subject to this option shall vest at the earlier of (i) June 7, 2020, or (ii) the date of the 2020 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan). Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 22:29 UTC |
SELICK HAROLD EDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $11.80 | $0.00 |
DisclosureSEC source: 0001209191-19-036207 · doc4.xml · derivative · entry 1 SELICK HAROLD E · CIK 0001287233 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2029-06-06 F1 · derivative.exercise_date: The shares subject to this option shall vest at the earlier of (i) June 7, 2020, or (ii) the date of the 2020 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan). Read SEC document |
| June 07, 2019 Filed Jun 11, 2019 22:20 UTC |
Giraudo BryanDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $11.80 | $0.00 |
DisclosureSEC source: 0001209191-19-036195 · doc4.xml · derivative · entry 1 Giraudo Bryan · CIK 0001740847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2029-06-06 F1 · derivative.exercise_date: The shares subject to this option shall vest at the earlier of (i) June 7, 2020, or (ii) the date of the 2020 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan). Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 23:40 UTC |
Kalkofen Donald A.Chief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $10.06 | $0.00 |
DisclosureSEC source: 0001209191-19-034082 · doc4.xml · derivative · entry 1 Kalkofen Donald A. · CIK 0001771066 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2029-05-30 F1 · derivative.exercise_date: This option vests over a four-year period with 25% of the shares underlying the option vesting on the one-year anniversary of the vesting commencement date of May 28, 2019, and the balance vesting in equal monthly installments over the following 36 months. Read SEC document |
| May 15, 2019 Filed May 16, 2019 22:43 UTC |
Saks Samuel RChief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $10.80 | $0.00 |
DisclosureSEC source: 0001209191-19-030616 · doc4.xml · derivative · entry 1 Saks Samuel R · CIK 0001365615 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2029-05-14 F1 · derivative.exercise_date: The stock option vests in 48 equal monthly installments following the date of grant. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 23:19 UTC |
SELICK HAROLD EDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,310 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001209191-19-022784 · doc4.xml · derivative · entry 2 SELICK HAROLD E · CIK 0001287233 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,310 shares Expires 2019-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock option vested in 36 equal monthly installments following the vesting commencement date. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 23:19 UTC |
SELICK HAROLD EDirector
|
Exercise / conversionCommon Stock | 3,310 | $1.31 | $4,336.10 |
DisclosureSEC source: 0001209191-19-022784 · doc4.xml · nonDerivative · entry 1 SELICK HAROLD E · CIK 0001287233 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 23:33 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
SaleCommon Stock | 2,183 | $8.03 | $17,529.49 |
DisclosureSEC source: 0001209191-19-015935 · doc4.xml · nonDerivative · entry 2 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 383,831 F2 · kind: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 23:35 UTC |
Liu David YChief Scientific Officer
|
SaleCommon Stock | 810 | $8.03 | $6,504.30 |
DisclosureSEC source: 0001209191-19-015939 · doc4.xml · nonDerivative · entry 2 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,197 F2 · kind: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 23:29 UTC |
Shames Richard S.Chief Medical Officer
|
SaleCommon Stock | 657 | $8.03 | $5,275.71 |
DisclosureSEC source: 0001209191-19-015927 · doc4.xml · nonDerivative · entry 2 Shames Richard S. · CIK 0001675878 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,021 F2 · kind: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 23:33 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 172,500 | $0.00 Strike: $8.02 | $0.00 |
DisclosureSEC source: 0001209191-19-015935 · doc4.xml · derivative · entry 3 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 172,500 Underlying: Common Stock · 172,500 shares Expires 2029-02-27 F3 · derivative.exercise_date: The stock option vests in 48 equal monthly installments following the date of grant. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 23:33 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
GrantCommon Stock | 28,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-015935 · doc4.xml · nonDerivative · entry 1 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 386,014 F1 · shares: Represents grant of the restricted stock units payable solely in common stock that vest in equal annual installments over four years from the grant date. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 23:32 UTC |
Saks Samuel RChief Development Officer
|
GrantStock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $8.02 | $0.00 |
DisclosureSEC source: 0001209191-19-015930 · doc4.xml · derivative · entry 2 Saks Samuel R · CIK 0001365615 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2029-02-27 F2 · derivative.exercise_date: The stock option vests in 48 equal monthly installments following the date of grant. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 23:32 UTC |
Saks Samuel RChief Development Officer
|
GrantCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-015930 · doc4.xml · nonDerivative · entry 1 Saks Samuel R · CIK 0001365615 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 F1 · shares: Represents grant of the restricted stock units payable solely in common stock that vest in equal annual installments over four years from the grant date. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 23:35 UTC |
Liu David YChief Scientific Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 90,000 | $0.00 Strike: $8.02 | $0.00 |
DisclosureSEC source: 0001209191-19-015939 · doc4.xml · derivative · entry 3 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2029-02-27 F3 · derivative.exercise_date: The stock option vests in 48 equal monthly installments following the date of grant. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 23:35 UTC |
Liu David YChief Scientific Officer
|
GrantCommon Stock | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-015939 · doc4.xml · nonDerivative · entry 1 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,007 F1 · shares: Represents grant of the restricted stock units payable solely in common stock that vest in equal annual installments over four years from the grant date. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 23:29 UTC |
Shames Richard S.Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 51,000 | $0.00 Strike: $8.02 | $0.00 |
DisclosureSEC source: 0001209191-19-015927 · doc4.xml · derivative · entry 3 Shames Richard S. · CIK 0001675878 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,000 Underlying: Common Stock · 51,000 shares Expires 2029-02-27 F3 · derivative.exercise_date: The stock option vests in 48 equal monthly installments following the date of grant. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 23:29 UTC |
Shames Richard S.Chief Medical Officer
|
GrantCommon Stock | 8,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-015927 · doc4.xml · nonDerivative · entry 1 Shames Richard S. · CIK 0001675878 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,678 F1 · shares: Represents grant of the restricted stock units payable solely in common stock that vest in equal annual installments over four years from the grant date. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 23:27 UTC |
Gupta SuneelEVP Clinical Operations
|
GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $8.02 | $0.00 |
DisclosureSEC source: 0001209191-19-015926 · doc4.xml · derivative · entry 2 Gupta Suneel · CIK 0001763923 · EVP Clinical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2029-02-27 F2 · derivative.exercise_date: The stock option vests in 48 equal monthly installments following the date of grant. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 23:27 UTC |
Gupta SuneelEVP Clinical Operations
|
GrantCommon Stock | 7,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-015926 · doc4.xml · nonDerivative · entry 1 Gupta Suneel · CIK 0001763923 · EVP Clinical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 F1 · shares: Represents grant of the restricted stock units payable solely in common stock that vest in equal annual installments over four years from the grant date. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 22:37 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
SaleCommon Stock | 10,132 | $7.71 | $78,117.72 |
DisclosureSEC source: 0001209191-19-008690 · doc4.xml · nonDerivative · entry 2 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,264 F1 · kind: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 22:37 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
SaleCommon Stock | 777 | $8.10 | $6,292.22 |
DisclosureSEC source: 0001209191-19-008690 · doc4.xml · nonDerivative · entry 1 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,396 F1 · kind: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 22:30 UTC |
Liu David YChief Scientific Officer
|
SaleCommon Stock | 3,821 | $7.74 | $29,561.55 |
DisclosureSEC source: 0001209191-19-008679 · doc4.xml · nonDerivative · entry 1 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,007 F1 · kind: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.71 to $8.1377, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 22:27 UTC |
Shames Richard S.Chief Medical Officer
|
SaleCommon Stock | 2,580 | $7.71 | $19,891.80 |
DisclosureSEC source: 0001209191-19-008675 · doc4.xml · nonDerivative · entry 2 Shames Richard S. · CIK 0001675878 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,178 F1 · kind: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| February 06, 2019 Filed Feb 8, 2019 22:27 UTC |
Shames Richard S.Chief Medical Officer
|
SaleCommon Stock | 198 | $8.15 | $1,613.70 |
DisclosureSEC source: 0001209191-19-008675 · doc4.xml · nonDerivative · entry 1 Shames Richard S. · CIK 0001675878 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,758 F1 · kind: The sales reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Read SEC document |
| January 15, 2019 Filed Jan 16, 2019 23:42 UTC |
Gupta SuneelEVP Clinical Operations
|
Exercise / conversionStock Option (right to buy) · Derivative | 110,000 | $0.00 Strike: $7.38 | $0.00 |
DisclosureSEC source: 0001209191-19-003994 · doc4.xml · derivative · entry 1 Gupta Suneel · CIK 0001763923 · EVP Clinical Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,000 Underlying: Common Stock · 110,000 shares Expires 2029-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option vesting each month, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 00:00 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 22,344 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0001209191-19-003606 · doc4.xml · derivative · entry 2 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,343 Underlying: Common Stock · 22,344 shares Expires 2025-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest on the one year anniversary of the vesting commencement date, and 1/36th of the remaining shares subject to the option shall vest on the last day of each month following the first anniversary of the vesting commencement date, subject to the Reporting Person continuing to be a service provider of the Issuer through each such date. Read SEC document |
| January 11, 2019 Filed Jan 15, 2019 00:00 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
Exercise / conversionCommon Stock | 22,344 | $1.16 | $25,919.04 |
DisclosureSEC source: 0001209191-19-003606 · doc4.xml · nonDerivative · entry 1 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,173 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2018 Filed Aug 18, 2018 00:25 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 54,700 | $0.00 Strike: $8.58 | $0.00 |
DisclosureSEC source: 0001209191-18-047547 · doc4.xml · derivative · entry 2 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,700 Underlying: Common Stock · 54,700 shares Expires 2028-08-14 F2 · derivative.exercise_date: 1/3rd of the total number of shares underlying this option shall vest on each of February 5, 2019, August 5, 2019 and February 5, 2020. Read SEC document |
| August 15, 2018 Filed Aug 18, 2018 00:25 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
GrantCommon Stock | 82,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-047547 · doc4.xml · nonDerivative · entry 1 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 345,829 F1 · shares: Represents grant of the restricted stock units payable solely in common stock that vest as follows: 1/3rd of the total number of shares shall vest on each of February 5, 2019, August 5, 2019 and February 5, 2020. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 20:29 UTC |
O'Neil Thomas P.Chief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 14,050 | $0.00 Strike: $8.58 | $0.00 |
DisclosureSEC source: 0001209191-18-047549 · doc4.xml · derivative · entry 2 O'Neil Thomas P. · CIK 0001640645 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,050 Underlying: Common Stock · 14,050 shares Expires 2028-08-14 F3 · derivative.exercise_date: 1/3rd of the total number of shares underlying this option shall vest on each of February 5, 2019, August 5, 2019 and February 5, 2020. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 20:29 UTC |
O'Neil Thomas P.Chief Financial Officer
|
GrantCommon Stock | 21,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-047549 · doc4.xml · nonDerivative · entry 1 O'Neil Thomas P. · CIK 0001640645 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,560 F1 · shares: Represents grant of the restricted stock units payable solely in common stock that vest as follows: 1/3rd of the total number of shares shall vest on each of February 5, 2019, August 5, 2019 and February 5, 2020. F2 · balance_after: Includes 602 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2018. Read SEC document |
| August 15, 2018 Filed Aug 18, 2018 00:28 UTC |
Shames Richard S.Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 12,500 | $0.00 Strike: $8.58 | $0.00 |
DisclosureSEC source: 0001209191-18-047548 · doc4.xml · derivative · entry 2 Shames Richard S. · CIK 0001675878 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Underlying: Common Stock · 12,500 shares Expires 2028-08-14 F3 · derivative.exercise_date: 1/3rd of the total number of shares underlying this option shall vest on each of February 5, 2019, August 5, 2019 and February 5, 2020. Read SEC document |
| August 15, 2018 Filed Aug 18, 2018 00:28 UTC |
Shames Richard S.Chief Medical Officer
|
GrantCommon Stock | 18,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-047548 · doc4.xml · nonDerivative · entry 1 Shames Richard S. · CIK 0001675878 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,956 F1 · shares: Represents grant of the restricted stock units payable solely in common stock that vest as follows: 1/3rd of the total number of shares shall vest on each of February 5, 2019, August 5, 2019 and February 5, 2020. F2 · balance_after: Includes 1,706 shares acquired by the Reporting Person under the Issuer's 2016 Employee Stock Purchase Plan on March 9, 2018. Read SEC document |
| August 15, 2018 Filed Aug 18, 2018 00:22 UTC |
Liu David YChief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 17,200 | $0.00 Strike: $8.58 | $0.00 |
DisclosureSEC source: 0001209191-18-047543 · doc4.xml · derivative · entry 2 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,200 Underlying: Common Stock · 17,200 shares Expires 2028-08-14 F2 · derivative.exercise_date: 1/3rd of the total number of shares underlying this option shall vest on each of February 5, 2019, August 5, 2019 and February 5, 2020. Read SEC document |
| August 15, 2018 Filed Aug 18, 2018 00:22 UTC |
Liu David YChief Scientific Officer
|
GrantCommon Stock | 25,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-047543 · doc4.xml · nonDerivative · entry 1 Liu David Y · CIK 0001675881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,828 F1 · shares: Represents grant of the restricted stock units payable solely in common stock that vest as follows: 1/3rd of the total number of shares shall vest on each of February 5, 2019, August 5, 2019 and February 5, 2020. Read SEC document |
| July 12, 2018 Filed Jul 13, 2018 22:36 UTC |
PATEL DINESH V PH DDirector · President and CEO
|
GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-042575 · doc4.xml · nonDerivative · entry 1 PATEL DINESH V PH D · CIK 0001120477 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 263,779 F1 · kind: This transaction involved a gift of securities by the Reporting Person to his son. Read SEC document |
| May 31, 2018 Filed May 31, 2018 22:29 UTC |
Saks Samuel RChief Development Officer
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $7.28 | $0.00 |
DisclosureSEC source: 0001209191-18-034472 · doc4.xml · derivative · entry 1 Saks Samuel R · CIK 0001365615 · Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2028-05-30 F1 · derivative.exercise_date: The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date of May 21, 2018, and 1/36th of the remaining shares subject to the option vesting each month. Read SEC document |
| May 29, 2018 Filed Jun 12, 2018 18:40 UTC |
KHOSLA CHAITAN PHDDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $6.98 | $0.00 |
DisclosureSEC source: 0001209191-18-037310 · doc4.xml · derivative · entry 1 KHOSLA CHAITAN PHD · CIK 0001135139 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2028-05-28 F1 · derivative.exercise_date: The shares subject to this option shall vest at the earlier on (i) May 29, 2019, or (ii) the date of the 2019 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan). Read SEC document |
| May 29, 2018 Filed Jun 12, 2018 18:43 UTC |
Noonberg Sarah B.Director
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $6.98 | $0.00 |
DisclosureSEC source: 0001209191-18-037312 · doc4.xml · derivative · entry 1 Noonberg Sarah B. · CIK 0001706301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2028-05-28 F1 · derivative.exercise_date: The shares subject to this option shall vest at the earlier on (i) May 29, 2019, or (ii) the date of the 2019 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan). Read SEC document |
| May 29, 2018 Filed Jun 12, 2018 18:50 UTC |
Shanafelt ArmenDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $6.98 | $0.00 |
DisclosureSEC source: 0001209191-18-037316 · doc4.xml · derivative · entry 1 Shanafelt Armen · CIK 0001656151 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2028-05-28 F1 · derivative.exercise_date: The shares subject to this option shall vest at the earlier on (i) May 29, 2019, or (ii) the date of the 2019 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan). Read SEC document |
| May 29, 2018 Filed Jun 12, 2018 22:55 UTC |
Williams Lewis TDirector
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $6.98 | $0.00 |
DisclosureSEC source: 0001209191-18-037318 · doc4.xml · derivative · entry 1 Williams Lewis T · CIK 0001475714 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2028-05-28 F1 · derivative.exercise_date: The shares subject to this option shall vest at the earlier on (i) May 29, 2019, or (ii) the date of the 2019 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan). Read SEC document |
| May 29, 2018 Filed Jun 12, 2018 22:52 UTC |
Waddill William D.Director
|
GrantStock Option (right to buy) · Derivative | 12,000 | $0.00 Strike: $6.98 | $0.00 |
DisclosureSEC source: 0001209191-18-037317 · doc4.xml · derivative · entry 1 Waddill William D. · CIK 0001553338 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2028-05-28 F1 · derivative.exercise_date: The shares subject to this option shall vest at the earlier on (i) May 29, 2019, or (ii) the date of the 2019 Annual Meeting of stockholders of the Issuer, subject to the non-employee director's continuous service with the Issuer through such dates. The shares subject to this option will vest in full upon completion of a Change in Control (as defined in the Issuer's 2016 Equity Incentive Plan). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.